Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 9, 2008Clinical Infectious DiseasesOpen Access

New Treatment Approach in Indian Visceral Leishmaniasis: Single‐Dose Liposomal Amphotericin B Followed by Short‐Course Oral Miltefosine

View Full Paper
Ask AI
Bookmark
Share

Authors

SSShyam SundarMRMadhukar RaiJCJaya Chakravarty

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sundar et al. (2008) studied this question.

synapsesocial.com/papers/6a7dd3dac108c8d3ff045b32https://doi.org/10.1086/591972
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study.2002 · 101 citations
  2. 2Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India1992 · 93 citations
  3. 3Amphotericin B Treatment for Indian Visceral Leishmaniasis: Conventional versus Lipid Formulations2004 · 189 citations
  4. 4Epidemic Visceral Leishmaniasis in Sudan: A Randomized Trial of Aminosidine plus Sodium Stibogluconate versus Sodium Stibogluconate Alone1993 · 126 citations
  5. 5Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trialCommentary: cost and resistance remain issues2001 · 167 citations